|
PTPLAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.649700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.816100E-03 |
| Normal-vs-Stage2 |
1.482160E-01 |
| Normal-vs-Stage3 |
4.236200E-01 |
| Normal-vs-Stage4 |
9.673200E-01 |
| Stage1-vs-Stage2 |
8.218600E-01 |
| Stage1-vs-Stage3 |
5.643900E-02 |
| Stage1-vs-Stage4 |
1.704110E-02 |
| Stage2-vs-Stage3 |
3.684400E-01 |
| Stage2-vs-Stage4 |
1.623950E-01 |
| Stage3-vs-Stage4 |
4.298200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.812200E-02 |
| Normal-vs-AfricanAmerican |
1.356110E-02 |
| Normal-vs-Asian |
7.342400E-02 |
| Caucasian-vs-AfricanAmerican |
2.244800E-01 |
| Caucasian-vs-Asian |
4.759000E-01 |
| AfricanAmerican-vs-Asian |
5.735600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.739210E-01 |
| Normal-vs-Female |
1.944290E-02 |
| Male-vs-Female |
4.574200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.381800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.815600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.626400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.505600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.619190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.654100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.639800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.699800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.494200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.473800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.040100E-04 |
| Classical-VS-Follicular |
4.733900E-02 |
| Classical-VS-Other |
1.151010E-01 |
| Classical-VS-Normal |
1.917580E-03 |
| Tall-VS-Follicular |
1.846000E-01 |
| Tall-VS-Other |
7.968800E-01 |
| Tall-VS-Normal |
5.049800E-01 |
| Follicular-VS-Other |
4.408800E-01 |
| Follicular-VS-Normal |
4.660600E-01 |
| Other-VS-Normal |
6.300000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.906200E-02 |
| Normal-vs-N1 |
3.938400E-01 |
| N0-vs-N1 |
1.641550E-02 |
|
|
